Biotech / CRO
Attract investment & partnerships
Alamar Biosciences has developed a novel technology to dramatically improve the detection of low-abundance proteins NULISA.
The use of target barcodes and sample barcodes in the NULISA enables the simultaneous, multiplexed measurements of hundreds to thousands of proteins in an automated, high-throughput manner with minimal hands-on time and low sample values.
The highly sensitive and specific NULISA is enabling the discovery and analysis of proteins that would otherwise be undetected by current methods.
“To create a visually appealing explainer video,
unlocking the power of proteomics."
Duration from the idea to the final delivery of the video (270 sec)
Communication with client is essential for us. To listen to them and provide with the best result
Two feedback rounds on the production stage
If you have any questions or wish to discuss contact us by filling out the form below.